In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Simcere Pharmaceutical completes $168.6mm IPO on NYSE

Executive Summary

Chinese branded generics firm Simcere Pharmaceutical Group has netted $168.6mm in an IPO on the NYSE. It sold 12.5mm American Depositary Shares (each representing two ordinary shares) at $7.25 apiece--the high end of its range. Selling stockholders sold an additional 3.13mm ADSs.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register